MoHAP launches E-service authorizing health facilities to dispose of pharmaceutical products as medical waste


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ MoHAP launches E-service authorizing health facilities to dispose of pharmaceutical products as medical waste
Aiming to enhance societal health and environmental safety, as well as to implement precautionary measures and physical distancing to prevent the spread of Covid-19 disease

The Ministry of Health and Prevention, MoHAP, has recently launched an E-service to dispose of expired and unusable medical and pharmaceutical products including controlled and uncontrolled medicines, in a proper way and as medical waste.

Aiming to enhance societal health and environmental safety, as well as to implement precautionary measures and physical distancing to prevent the spread of Covid-19 disease, the service comes as part of a host of e-services, to enhance innovate smart solutions, as well as to commit to implement quality systems and contribute to developing program and plans tailored to boost the efficiency of the health system.

The service is accessible all the time through smartphones, where the owners and employees of health and pharmaceutical institutions can easily submit the form, and with the possibility of saving all records and documents.

Boosting the smart transformation of regulatory services

Dr Hessa Ali Mubarak, Director of Health Empowerment and Compliance Department, explained that the service comes within the framework of the smart and E-transformation of regulatory and supervisory services on health facilities and pharmacies. This would help bolster MoHAP’s strategy to provide fair, comprehensive, and innovative healthcare services as per international standards, through sophisticated and integrated health legislation that entrenches the development of distinctive services for the health sector.

“The service includes 5 categories, including uncontrolled medicines that are imported by a local agent, the controlled medicines of the second group listed in the Ministry’s resolution No. 888 of 2016, which are traded and imported by a local agent and distributed to licensed pharmacies and medical warehouses, medicines and drugs which imported by MoHAP’s licensed warehouses according to a purchase order by public or private hospitals, all the pharmaceutical raw materials, drugs medicines and nutritional supplements that are prescribed by medical prescription ,” Dr Hessa elaborated.

Meanwhile, the Ministry of Health and Prevention, MoHAP, announced on Saturday that it conducted 70,079 additional COVID-19 tests over the past 24 hours, using state-of-the-art medical testing equipment.

In a statement, the Ministry stressed its aim to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment.

As part of its intensified testing campaign, MoHAP announced 424 new coronavirus cases, bringing the total number of cases in the UAE to 66,617.

According to the Ministry, the infected individuals are from various nationalities, are in a stable condition, and are receiving the necessary care.

MoHAP also announced two deaths due to COVID-19 complications, bringing the total number of deaths in the country to 372.

The Ministry expressed its sincere condolences to the families of the deceased and wished current COVID-19 patients a speedy and full recovery, calling on all members of the society to cooperate with health authorities, adhere to the instructions and physical distance to ensure the health and safety of all.

MoHAP also noted an additional 112 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 58,408.

Tags : #MoHAP #PhysicalDistancing #DrHessaAliMubarak #EnvironmentalSafety

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026